Site Logo

Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.

Publications & Posters

Rare Genodermatoses

  • Doux J. Barriers and Opportunities A View Across the Developmental Divide. Journal of Investigative Dermatology (2015) 135, 2143–2144. [Download Now]
  • Chavez A, Licholai G, Murrell DF. Patients Left Behind: Rare dermatologic conditions miss the orphan drug development boom.  J Am Acad Dermatol (2019). [ Download Now]
   

Pachyonychia Congenita

  • Hickerson R, Leake D, Pho LN, Leachman SA, Kaspar RL. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. J Dermatol Science (2010). [View Abstract]
  • Voice of the Patient: Report from the Pachyonychia Congenita Externally-Led Patient Focused Drug Development Meeting. April 6, 2018. [Download Now]
  • Gallagher et al., Prevalence of Diagnosed/Highly Symptomatic Pachyonychia Congenita (PC) Patients Managed Annually by US Dermatologists-National Real World Occurrence (RWO) Physician Study. J Dermatol Dis 2019, 6:1  [Download Now]
  • Shroot B., Evans H., Schwartz J. Gene Mutations Often Leave Individuals with Pachyonychia Congenita Unable to Walk Due to Severe Plantar Pain. Poster presentation at PeDRA, Oct 22, 2020. [Download Now]
   

Gorlin Syndrome

  • Kim AL, Back JH, Chaudhary SC, Zhu Y, Athar M, Bickers DR. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas. Journal of Investigative Dermatology (2018) 138,1716e1725. [Download Now]
   

Clinical Research Innovation

  • Evans H, Schwartz J., Pellegrini C., Nauss J., Cook E. Patient-centric Approach Enables Individuals with Limited Mobility to Participate in Clinical Studies. . Poster presentation at PeDRA, Oct 22, 2020. [Download Now]